These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 3180817)

  • 21. Factors modifying the secretion and action of parathyroid hormone in renal failure.
    Cundy TF; Hamdy NA; Kanis JA
    Contrib Nephrol; 1988; 64():5-15. PubMed ID: 3053038
    [No Abstract]   [Full Text] [Related]  

  • 22. [Pathophysiology and treatment of renal osteodystrophy].
    Ionova D
    Vutr Boles; 1985; 24(6):23-9. PubMed ID: 3913143
    [No Abstract]   [Full Text] [Related]  

  • 23. [Renal osteodystrophy: aluminium and secondary hyperparathyroidism].
    de Vernejoul MC
    Rev Prat; 1990 Mar; 40(7):613-8. PubMed ID: 2326587
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Bone biopsy studies in the diagnosis and treatment of renal osteodystrophy.
    Sebert JL; Fardellone P; Noel C; Cohen-Solal M; Bellony R; Marie A; Fournier A
    Contrib Nephrol; 1988; 64():49-57. PubMed ID: 3180824
    [No Abstract]   [Full Text] [Related]  

  • 25. Mineral and bone disorders in patients on dialysis: physiology and clinical consequences.
    McCarley PB; Arjomand M
    Nephrol Nurs J; 2008; 35(1):59-64. PubMed ID: 18372764
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Parathyroid and bone. Management of parathyroid function and evaluation of bone metabolism in hemodialysis patients].
    Goto S; Fukagawa M
    Clin Calcium; 2007 Dec; 17(12):1830-4. PubMed ID: 18057657
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Renal osteodystrophy: past and future.
    Slatopolsky E; Lopez-Hilker S; Dusso A; Brown A; Delmez J; Martin K
    Contrib Nephrol; 1990; 78():38-45; discussion 45-6. PubMed ID: 2225842
    [No Abstract]   [Full Text] [Related]  

  • 28. Evolution of renal osteodystrophy: correlation of bone histomorphometry and serum mineral and immunoreactive parathyroid hormone values before and after treatment with calcium carbonate or 25-hydroxycholecalciferol.
    Bordier PJ; Marie PJ; Arnaud CD
    Kidney Int Suppl; 1975 Jan; (2):102-12. PubMed ID: 1057669
    [No Abstract]   [Full Text] [Related]  

  • 29. [Prevention and treatment of renal osteodystrophy: present and future].
    Fernández E; Craver L
    Nefrologia; 2006; 26 Suppl 3():19-27. PubMed ID: 17469423
    [No Abstract]   [Full Text] [Related]  

  • 30. Bone disease in pediatric patients undergoing dialysis with CAPD or CCPD.
    Salusky IB; Coburn JW; Brill J; Foley J; Slatopolsky E; Fine RN; Goodman WG
    Kidney Int; 1988 May; 33(5):975-82. PubMed ID: 3392886
    [TBL] [Abstract][Full Text] [Related]  

  • 31. How important is phosphate in the pathogenesis of renal osteodystrophy?
    Slatopolsky E; Rutherford WE; Hruska K; Martin K; Klahr S
    Arch Intern Med; 1978 May; 138 Spec No():848-52. PubMed ID: 646572
    [No Abstract]   [Full Text] [Related]  

  • 32. Relative hypoparathyroidism and adynamic bone disease.
    Mucsi I; Hercz G
    Am J Med Sci; 1999 Jun; 317(6):405-9. PubMed ID: 10372841
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Renal osteodystrophy in end-stage renal failure.
    Nortman DF; Coburn JW
    Postgrad Med; 1978 Nov; 64(5):123-30. PubMed ID: 714829
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Renal osteodystrophy and vitamin D derivatives: cellular mechanisms of hyperparathyroidism in uremia.
    Fukagawa M; Kurokawa K
    J Nutr Sci Vitaminol (Tokyo); 1992; Spec No():96-9. PubMed ID: 1338454
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Renal osteodystrophy.
    González EA; Martin KJ
    Rev Endocr Metab Disord; 2001 Apr; 2(2):187-93. PubMed ID: 11705324
    [No Abstract]   [Full Text] [Related]  

  • 36. Use of the deferoxamine infusion test in the diagnosis of aluminum-related osteodystrophy.
    Milliner DS; Nebeker HG; Ott SM; Andress DL; Sherrard DJ; Alfrey AC; Slatopolsky EA; Coburn JW
    Ann Intern Med; 1984 Dec; 101(6):775-9. PubMed ID: 6208838
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Renal osteodystrophy: bone disease with renal disease].
    Shigematsu T
    Nihon Rinsho; 2002 Mar; 60 Suppl 3():435-42. PubMed ID: 11979940
    [No Abstract]   [Full Text] [Related]  

  • 38. Parathyroid dysfunction end stage renal disease.
    DiTella PJ; Lang GR
    Otolaryngol Clin North Am; 1980 Feb; 13(1):193-201. PubMed ID: 7367004
    [No Abstract]   [Full Text] [Related]  

  • 39. Persistent secondary hyperparathyroidism.
    Ağbaht K; Güllü S
    Acta Clin Belg; 2011; 66(2):149. PubMed ID: 21630618
    [No Abstract]   [Full Text] [Related]  

  • 40. Renal osteodystrophy.
    Beale MG; Salcedo JR; Ellis D; Rao DD
    Pediatr Clin North Am; 1976 Nov; 23(4):873-84. PubMed ID: 186748
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.